SCHEMBL21596790

SCHEMBL21596790

CCOCc1cc(F)c(C#N)c(OC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 3/20 0.38
HSD17B10 Q99714 2/20 0.38
HPGD P15428 1/20 0.38
CACNA1H O95180 1/20 0.37
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
TRPV4 Q9HBA0 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
GRM2 Q14416 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31432811 0.89 ALDH1A1 (0.42) ALDH1A1KDM4EHSD17B10HPGDMAPK1
SCHEMBL21596854 0.86 NPC1 (0.39) ALDH1A1KDM4EHSD17B10HPGDCACNA1H
SCHEMBL21596799 0.85 MAPT (0.42) ALDH1A1KDM4EHSD17B10CACNA1HMAPK1
SCHEMBL12763938 0.84 PTGS2 (0.48) ALDH1A1KDM4EHSD17B10HPGDCACNA1H
SCHEMBL22802480 0.81 CACNA1H (0.39) ALDH1A1KDM4EHSD17B10CACNA1HMAPK1
SCHEMBL21596827 0.80 CACNA1H (0.41) ALDH1A1KDM4EHSD17B10CACNA1HMAPK1
SCHEMBL15955655 0.77 CACNA1H (0.39) ALDH1A1KDM4EHSD17B10CACNA1HMAPK1
SCHEMBL31432491 0.77 CACNA1H (0.39) ALDH1A1KDM4EHSD17B10HPGDCACNA1H
SCHEMBL15955546 0.77 TNKS2 (0.41) ALDH1A1HSD17B10CACNA1HMAPK1CYP1A2
SCHEMBL25564462 0.74 CYP3A4 (0.45) ALDH1A1KDM4EHSD17B10HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062393-A1 Compounds CTXT PTY LTD (AU) 2026-03-05 US disclosed
US-12365655-B2 Compounds CTXT PTY LTD (AU) 2025-07-22 US disclosed
CN-112334466-B Compounds of formula (I) CTXT私人有限公司 2025-05-30 CN disclosed
EP-4335439-A2 COMPOUNDS CTXT PTY LTD (AU) 2024-03-13 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
EP-3810602-A1 COMPOUNDS CTXT Pty Limited (AU) 2021-04-28 EP disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 ALDH1A1 981/4885KDM4E 4009/4885HSD17B10 298/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 ALDH1A1 982/4885KDM4E 4009/4885HSD17B10 299/4885
US-20260062393-A1 Compounds SCN2B, ABCB11, SCN1B ALDH1A1 1864/4885KDM4E 800/4885HSD17B10 863/4885
US-12365655-B2 Compounds SLC10A1, ABCB11, PCSK9 ALDH1A1 982/4885KDM4E 4009/4885HSD17B10 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.